Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Arthritis, Juvenile Chronic

cetylpyridinium chloride anhydrous has been researched along with Arthritis, Juvenile Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allantaz, F; Allman, W; Ardura, M; Banchereau, J; Bennett, L; Chaussabel, D; Chung, W; Mejias, A; Palucka, K; Pascual, V; Punaro, M; Ramilo, O; Smith, E; Stichweh, D; Wise, C1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Arthritis, Juvenile Chronic

ArticleYear
Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade.
    The Journal of experimental medicine, 2007, Sep-03, Volume: 204, Issue:9

    Topics: Adolescent; Adult; Age of Onset; Aged; Arthritis, Juvenile; Case-Control Studies; Child; Chloride Channels; Communicable Diseases; Diagnosis, Differential; Gene Expression Profiling; Health; Humans; Infant; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Leukocytes, Mononuclear; Middle Aged; Oligonucleotide Array Sequence Analysis; Transcription, Genetic

2007